Reproducibility Passport · Methylated DNA Immunoprecipitation Sequencing (MeDIP-seq) of 5-Hydroxymethylcytosine-Independent 5mC Enrichment in Human Glioblastoma U87-MG DNA — Olto Discovery
Completeness score: 50 out of 100, grade D
D
50/100
Reproducibility Passport
Methylated DNA Immunoprecipitation Sequencing (MeDIP-seq) of 5-Hydroxymethylcytosine-Independent 5mC Enrichment in Human Glioblastoma U87-MG DNA
Grade D · Early-stageGenomics
A deterministic, publicly-verifiable summary of how reproducible and transparent this protocol is, computed from open signals only and never from private lab data.
Reproducibility dimensions
Methodological rigor
86
6 of 7 reproducibility signals present.
Passed:
Experimental controlsControls are specified for valid comparison.
Passed:
ReplicationBiological/technical replicates are described.
Passed:
Sample size / powerSample size or power is justified.
Not yet met:
Statistical analysisNo statistical method stated — name the test(s) and significance threshold up front.
How to strengthen this passport
No statistical method stated — name the test(s) and significance threshold up front.
Reference a recognized standard your method follows (e.g. ISO 17025, ASTM, USP, 21 CFR Part 11).
Add a references section citing the sources your method builds on.
Link the author ORCID iD for verifiable attribution.
Iterate and version the protocol — a revision history strengthens provenance.
Verifiable artifact
This passport is reproducible: anyone can recompute it from the public protocol. Cite it with the canonical URL below.
Methylated DNA Immunoprecipitation Sequencing (MeDIP-seq) of 5-Hydroxymethylcytosine-Independent 5mC Enrichment in Human Glioblastoma U87-MG DNA [Reproducibility Passport]. (2026). Olto Discovery. https://www.oltodiscovery.com/passport/methylated-dna-immunoprecipitation-sequencing-medip-seq-d1f01c